News & Events CTI Announces Expansion in Texas and California

CTI Announces Expansion in Texas and California

June 11, 2019

FOR IMMEDIATE RELEASE [11, June 2019] - CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization announces the opening of new offices in Dallas, TX and San Diego, CA. The Dallas location was chosen because of its proximity to local medical centers, allowing team members and visiting pharmaceutical sponsors easier access to contacts and resources surrounding the academic research centers. The San Diego office is in La Jolla and was chosen because of the area's reputation as the biotech hub of southern California. CTI currently collaborates with many southern California biotechnology companies and academic centers. 

A 84dee 50-33a 7-4753-9a 41-75a 71292887f

9950011d -aae 6-468f -bda 4-133ae 66ff 7aa

"We are thrilled to expand our workforce in Dallas and San Diego," remarks Timothy J. Schroeder, Founder and CEO. "Both locations are rich with talent, and we look forward to the opportunities that will come from becoming a part of those communities. We have a very long history of successful collaborations in both areas with leading academic centers and emerging biotechnology companies and are excited to expand our team in both cities."

CTI, with an annual staff retention rate of 95%, has been working for two decades in the drug development industry across North America, Europe, South America, Pac-Asia, and Africa, specializing in clinical research programs involving critically ill patient populations, and has more than 30 offices worldwide to serve more than 200 pharmaceutical, biotechnology, and medical device clients. The company recently announced additional growth in the US in Raleigh, NC and San Francisco, CA.

Subscribe to our mailing list

* indicates required